RECRUITING

UWCCC Molecular Tumor Board Registry

Talk to us

Conditions

Hematologic NeoplasmsSolid Neoplasm

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.

Official Title

UWCCC Precision Medicine Molecular Tumor Board Registry

Quick Facts

Study Start:2016-03-30
Study Completion:2027-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03023202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Clinically suspected or histologically confirmed solid or hematological malignancy
  2. * Undergoing genetic testing of tumor
  3. * Ability to understand written informed consent document
  4. * Willingness to sign written informed consent document
  1. * Pediatric patients (age\<18 years) will be excluded due to a lack of expertise on the molecular tumor committee

Contacts and Locations

Study Contact

Cancer Connect
CONTACT
8006228922
clinicaltrials@cancer.wisc.edu

Principal Investigator

Mark Burkard, MD, PhD
PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison

Study Locations (Sites)

University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792
United States

Collaborators and Investigators

Sponsor: University of Wisconsin, Madison

  • Mark Burkard, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-03-30
Study Completion Date2027-03

Study Record Updates

Study Start Date2016-03-30
Study Completion Date2027-03

Terms related to this study

Additional Relevant MeSH Terms

  • Hematologic Neoplasms
  • Solid Neoplasm